Page last updated: 2024-10-17

phloroglucinol and Leishmaniasis, Visceral

phloroglucinol has been researched along with Leishmaniasis, Visceral in 1 studies

Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rachidi, N1
Taly, JF1
Durieu, E1
Leclercq, O1
Aulner, N1
Prina, E1
Pescher, P1
Notredame, C1
Meijer, L1
Späth, GF1

Other Studies

1 other study available for phloroglucinol and Leishmaniasis, Visceral

ArticleYear
Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Animals; Benzamides; Casein Kinase I; Conserved Sequence; Cricetinae; Female; Imidazoles; Indoles; I

2014